HSPA9 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 73.7 kDa observed
Observed band 73.7 kDa observed
Gel 12-15%
Positive control Adrenal gland
Negative control Skeletal muscle
Important caveats
Reasons your observed band may differ from the expected size.
Calculated mass73.7 kDa
LocalizationMitochondrion / Nucleus, nucleolus
Processing / PTMRecord-dependent
ReactivityHuman / Mouse / Rat
Section 1

Real Curated HSPA9 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdrenal gland
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryPA1789 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected HSPA9 Western Blot Band Size?

Use the product-observed 73.7 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
73.7 kDaMatches the authoritative product WB observation.
73.7 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected HSPA9 appearancePlan around 73.7 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band73.7 kDa; use this as the primary experimental expectation.
Calculated mass73.7 kDa from UniProt P38646; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with PA1789.
Why is my band missing or off?
SituationLikely causeNext action
73.7 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for HSPA9 Western blot

🧪Use Adrenal gland as the first positive-control candidate and retain an orthogonal negative control.
Positive control: Adrenal gland (High)
Negative control: Skeletal muscle (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for HSPA9

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue Cell type Level Evidence Source
Adrenal gland Reported tissue cells High Protein (HPA) HPA →
Breast Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →
Bone marrow Reported tissue cells High Protein (HPA) HPA →
Adipose tissue Reported tissue cells Low Protein (HPA) HPA →

Undetected expression · recommended negative controls

Tissue Cell type Level Evidence Source
Skeletal muscle Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced HSPA9 Western Blot Tips

Deeper troubleshooting and optimisation questions for HSPA9, answered from its protein features.

Which band should guide the blot?
Use 73.7 kDa, the observation attached to the authoritative PA1789 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 73.7 kDa expectation.
Which positive control should I start with?
Start with Adrenal gland, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Skeletal muscle as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for HSPA9 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PA1789 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

HSPA9 Western Blot Reagents

Human/Mouse/Rat-reactive HSPA9 Western blot reagents with authoritative product imagery.

Real WB dataWestern blot validation image for HSPA9 using PA1789; observed band 73.7 kDa
Anti-Grp75/HSPA9 Antibody Picoband®
Cat # PA1789
Real WB dataWestern blot validation image for HSPA9 using M02561-2; observed band 73.7 kDa
Anti-Grp75 Antibody Picoband® (monoclonal, 4I9)
Cat # M02561-2
Real WB dataWestern blot validation image for HSPA9 using PB9642; observed band 73.7 kDa
Anti-Grp75/HSPA9 Antibody Picoband®
Cat # PB9642

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.